Gene · 407009
Papers2,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma. | World J Gastroenterol | 2023 | 37664153 | PubTator, text mining | PubMed |
| Differentially expressed non-coding RNAs and their regulatory networks in liver cancer. | Heliyon | 2023 | 37662778 | PubTator, text mining | PubMed |
| Demonstration of the impact of COVID-19 on metabolic associated fatty liver disease by bioinformatics and system biology approach. | Medicine (Baltimore) | 2023 | 37657050 | PubTator, text mining | PubMed |
| Cytotoxicity Analysis and In Silico Studies of Three Plant Extracts with Potential Application in Treatment of Endothelial Dysfunction. | Pharmaceutics | 2023 | 37631338 | PubTator, text mining | PubMed |
| Proliferative Vitreoretinopathy: A Reappraisal. | J Clin Med | 2023 | 37629329 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Features of Uveal Melanoma-An Overview and Clinical Implications. | Int J Mol Sci | 2023 | 37628989 | PubTator, text mining | PubMed |
| Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers. | Int J Mol Sci | 2023 | 37628978 | PubTator, text mining | PubMed |
| Circulating Biomarkers Associated with the Diagnosis and Prognosis of B-Cell Progenitor Acute Lymphoblastic Leukemia. | Cancers (Basel) | 2023 | 37627214 | PubTator, text mining | PubMed |
| Identification and analysis of methylation signature genes and association with immune infiltration in pediatric acute myeloid leukemia. | J Cancer Res Clin Oncol | 2023 | 37606761 | PubTator, text mining | PubMed |
| MicroRNAs miR-16 and miR-519 control meningioma cell proliferation via overlapping transcriptomic programs shared with the RNA-binding protein HuR. | Front Oncol | 2023 | 37601663 | PubTator, text mining | PubMed |
| MiR-196b-5p activates NF-κB signaling in non-small cell lung cancer by directly targeting NFKBIA. | Transl Oncol | 2023 | 37595393 | PubTator, text mining | PubMed |
| MiR-183-5p promotes renal cell carcinoma metastasis by targeting TET1. | Int J Immunopathol Pharmacol | 2023 | 37584255 | PubTator, text mining | PubMed |
| Recent advances microRNAs and metabolic reprogramming in colorectal cancer research. | Front Oncol | 2023 | 37576895 | PubTator, text mining | PubMed |
| Circulating miR-206 and miR-1246 as Markers in the Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease. | Int J Mol Sci | 2023 | 37569812 | PubTator, text mining | PubMed |
| Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers. | Int J Mol Sci | 2023 | 37569782 | PubTator, text mining | PubMed |
| Advances in the Early Detection of Hepatobiliary Cancers. | Cancers (Basel) | 2023 | 37568696 | PubTator, text mining | PubMed |
| Editorial: Bioinformatics analysis of omics data for biomarker identification in clinical research, Volume II. | Front Genet | 2023 | 37554403 | PubTator, text mining | PubMed |
| Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma. | Front Oncol | 2023 | 37546394 | PubTator, text mining | PubMed |
| A spotlight on the interplay between Wnt/β-catenin signaling and circular RNAs in hepatocellular carcinoma progression. | Front Oncol | 2023 | 37546393 | PubTator, text mining | PubMed |
| TAZ upregulates MIR-224 to inhibit oxidative stress response in multiple myeloma. | Cancer Rep (Hoboken) | 2023 | 37539777 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407009/papers?page=7